Pharma BD Deal Intelligence

Sekisui Chemical Co., Ltd. / Genzyme Diagnostic Products business

2010 · Asset Purchase · $265M · Complete

Announcement Sentiment

Strongly positive

Genzyme agreed to sell Diagnostics business to Sekisui Chemical for $265M cash. 2009 revenue $167M with ~575 employees. Closed February 1, 2011.

Did it work? Outcome assessment

Strategic verdict

Achieved Stated Rationale

Pipeline outcome

Assets Advanced

Assessment window: 5yr post-close.

Announced Nov 18, 2010
Closed Feb 01, 2011
Deal value $265M
Deal type Asset Purchase
Therapeutic area Cardiovascular, diabetes, renal, infectious disease diagnostics
Indications Cardiovascular, diabetes, renal, infectious disease diagnostics
Key assets Clinical chemistry reagents; rapid tests; infectious disease diagnostics
Mechanism In-vitro diagnostic reagents